Teeple, A.; Muser, E. Cost Per Responder Analysis of Guselkumab Versus Adalimumab Using Efficacy Results Fromm a Head-to-Head Clinical Trial in Patients With Moderate to Severe Plaque Psoriasis. J of Skin 2017, 1, s6.